Geneos Wealth Management’s Douglas Elliman DOUG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-309
Closed -$1K 2163
2022
Q2
$1K Hold
309
﹤0.01% 2477
2022
Q1
$2K Buy
+309
New +$2.34K ﹤0.01% 2535

Other funds holding DOUG

Geneos Wealth Management's DOUG Position: Q3 2022 in Review

Geneos Wealth Management sold out of Douglas Elliman (DOUG) in Q3 2022, closing a stake of 309 shares — an estimated $1K sold.

Geneos Wealth Management first reported a position in DOUG in Q1 2022 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 171 funds tracked by Wall St. Rank hold DOUG as of Q3 2022.

  • Geneos Wealth Management reported no remaining Douglas Elliman position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 309 Douglas Elliman shares in Q3 2022, an estimated $1K.
  • Geneos Wealth Management first reported a position in Douglas Elliman in Q1 2022 and held it in 2 quarters.
  • Geneos Wealth Management's Douglas Elliman position peaked at $2K in Q1 2022.
  • 171 funds tracked by Wall St. Rank held Douglas Elliman as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.